sharetrader
Page 1 of 31 1234511 ... LastLast
Results 1 to 10 of 301
  1. #1
    Share Collector
    Join Date
    Mar 2005
    Location
    Porirua
    Posts
    3,509

    Default MHM Automation - MHM

    Could have sworn there was an MGL thread somewhere out there, but all the search would give me was the rather ancient BWY thead:
    http://www.sharetrader.co.nz/showthr...Industries-Ltd

    New management team in 2011 seem to be pulling things back on track. Combined with strong dairy industry demand (new production lines), potential residential building demand increase, growth from acquisitions (Titan Slicers) and launch of new products (e.g. today's announcement - previously foreshadowed - of North American licence agreement for the S-Clave technology). All starts to look like a baby version of SCT.

    Okay, so 21 cps ($58m market cap) is probably more than a little overpriced... compare with SCT at $89m market cap and generating a $5m+ NPAT, whereas MGL managed just $0.8m. However, licensing revenues have the potential to drop through to bottom line rather nicely, so could provide a bit of a boost - especially should S-clave consumables start to kick in around 3-4 years away.

    Should be a good first half due to strong order book and initial licence fee, so could be worth a short term trade for now, but otherwise just a heads up as one to keep a lazy eye on. AGM tomorrow may give further guidance.
    Last edited by Lizard; 29-10-2021 at 05:43 PM. Reason: Change Name and Ticker

  2. #2
    Senior Member
    Join Date
    Nov 2012
    Location
    Auckland
    Posts
    1,347

    Default

    The stock definitely has potential. From the annoucement...
    "the deal should result in Mercer receiving an average royalty of at least 5%"
    and
    "Mercer estimates the North American sterilization market, including consumables, to be US$1.8 billion per annum"

  3. #3
    Senior Member
    Join Date
    Nov 2012
    Location
    Auckland
    Posts
    1,347

    Default

    Did anybody go to the AGM? Would have expected the AGM Presentation to be released by now. This would ensure all participants were equally informed.

    Pity. Another cross for the company.

  4. #4
    Senior Member
    Join Date
    Nov 2012
    Location
    Auckland
    Posts
    1,347

    Default

    Quote Originally Posted by noodles View Post
    Did anybody go to the AGM? Would have expected the AGM Presentation to be released by now. This would ensure all participants were equally informed.

    Pity. Another cross for the company.
    They must have heard me curse. The presentation is released.

    Only interesting thing to note was that they were looking at funding options for the commercialization of s-clave. (capital raising perhaps?)

  5. #5
    Share Collector
    Join Date
    Mar 2005
    Location
    Porirua
    Posts
    3,509

    Default

    Yes, unclear whether the presentation triggered the sell, but a possible. $3m headroom on the banking facility, but then they say looking at funding options to commercialise S-clave ($2m). So suggestion there is both a cap raise AND that they may be soaking up working capital in the rest of the business.

    Good and bad. Still think it is watchlist material - and would be good for it to get back to 10-14cps...

  6. #6
    Advanced Member
    Join Date
    Dec 2009
    Location
    Eastern BoP..
    Posts
    1,808

    Default

    Quote Originally Posted by Lizard View Post
    Yes, unclear whether the presentation triggered the sell, but a possible. $3m headroom on the banking facility, but then they say looking at funding options to commercialise S-clave ($2m). So suggestion there is both a cap raise AND that they may be soaking up working capital in the rest of the business.

    Good and bad. Still think it is watchlist material - and would be good for it to get back to 10-14cps...
    One of the more interesting ones IMHO Liz..

    But there are so many :-)

  7. #7
    Advanced Member
    Join Date
    Dec 2009
    Location
    Eastern BoP..
    Posts
    1,808

    Default

    Quote Originally Posted by noodles View Post
    The stock definitely has potential. From the annoucement...
    "the deal should result in Mercer receiving an average royalty of at least 5%"
    and
    "Mercer estimates the North American sterilization market, including consumables, to be US$1.8 billion per annum"
    To much enthusiasm noodles.. Down boy.. Down !!..

  8. #8
    Senior Member
    Join Date
    Nov 2012
    Location
    Auckland
    Posts
    1,347

    Default

    Quote Originally Posted by janner View Post
    To much enthusiasm noodles.. Down boy.. Down !!..
    Agreed. I will wait for it to become reasonably priced on it's current earnings. Then s-clave can be a free upside option.

  9. #9
    On the doghouse
    Join Date
    Jun 2004
    Location
    , , New Zealand.
    Posts
    9,221

    Default

    Quote Originally Posted by Lizard View Post
    New management team in 2011 seem to be pulling things back on track. Combined with strong dairy industry demand (new production lines), potential residential building demand increase, growth from acquisitions (Titan Slicers) and launch of new products (e.g. today's announcement - previously foreshadowed - of North American licence agreement for the S-Clave technology). All starts to look like a baby version of SCT.

    Okay, so 21 cps ($58m market cap) is probably more than a little overpriced... compare with SCT at $89m market cap and generating a $5m+ NPAT, whereas MGL managed just $0.8m. However, licensing revenues have the potential to drop through to bottom line rather nicely, so could provide a bit of a boost - especially should S-clave consumables start to kick in around 3-4 years away.

    AGM tomorrow may give further guidance.
    Reviewing the AGM presentation to see how 'baby SCT' measures up. The profit history looks terrible (p3) five years of solid losses before the modest profit this year. Perhaps this is a result of the multisector push into IP (p15)? The 'Leak Detector' has finally been completed, so at last all of those losses that plagued the company in prior years have been stemmed?

    Now we go to the balance sheet, page 27 of the FY2013 Annual Report. Trade receivables roughly match trade payables -OK. My main concern is the increase in borrowings (note 20, FY2013 report) up from $4.967m (FY2012) up to $6.337m (FY2013). Now $6.337m on total assets of $31.086m represents total long and short term debt to equity apportionment on 20:80. Pretty good, but not in the league of SCT who have a policy of zero term debt.

    ROE based on shareholder equity of $17.233m and $0.778m of profit ignoring currency translation differences is just 4.5%.

    Poor little baby! Perhaps best to put him back in the intensive care business incubator for another year and see what happens. I think he will pull through but he needs some better numbers behind him before I would become a supporter.

    SNOOPY

    discl: hold SCT and it is analyses like these that make me realize what a good investment, in relative terms, it is
    Watch out for the most persistent and dangerous version of Covid-19: B.S.24/7

  10. #10
    Guru
    Join Date
    Jul 2002
    Location
    New Zealand.
    Posts
    4,411

    Default

    WOW approx. 11% changed hands today, whose selling and WHATSUP ?

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •